{"transactions":[{"id":890694,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T17:26:26.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":682500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option\nwill vest on each monthly anniversary of the grant date such that the option will\nbe fully vested on February 20, 2030, subject to the reporting person continuing to\nprovide service to the Issuer through each such vesting date."}],"balance_after":682500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":682500},"source":{"system":"sec-edgar","filing":"0001670579-26-000002","document":"wk-form4_1771626383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057926000002/wk-form4_1771626383.xml","form_type":"4"}},{"id":890693,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-20T17:26:26.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":151700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":447150,"source":{"system":"sec-edgar","filing":"0001670579-26-000002","document":"wk-form4_1771626383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057926000002/wk-form4_1771626383.xml","form_type":"4"}},{"id":1203742,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-17T08:01:22.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.02,"value":20400.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades on 3/14/2025 at prices ranging from $1.00 to $1.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the specified range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse."}],"balance_after":3369395,"source":{"system":"sec-edgar","filing":"0001670579-25-000008","document":"wk-form4_1742212876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000008/wk-form4_1742212876.xml","form_type":"4"}},{"id":1252955,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:21:07.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":618250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":618250,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":618250},"source":{"system":"sec-edgar","filing":"0001670579-25-000003","document":"wk-form4_1740187261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000003/wk-form4_1740187261.xml","form_type":"4"}},{"id":1252954,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-21T20:21:07.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":136750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":295450,"source":{"system":"sec-edgar","filing":"0001670579-25-000003","document":"wk-form4_1740187261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000003/wk-form4_1740187261.xml","form_type":"4"}},{"id":1479076,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-14T20:22:52.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":58178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":87615,"source":{"system":"sec-edgar","filing":"0001415889-24-016907","document":"form4-06142024_080648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924016907/form4-06142024_080648.xml","form_type":"4"}},{"id":1625413,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:18:24.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":546950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":546950,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":546950},"source":{"system":"sec-edgar","filing":"0001628280-24-006421","document":"wk-form4_1708640281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000162828024006421/wk-form4_1708640281.xml","form_type":"4"}},{"id":1625412,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-22T17:18:24.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":118700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":158700,"source":{"system":"sec-edgar","filing":"0001628280-24-006421","document":"wk-form4_1708640281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000162828024006421/wk-form4_1708640281.xml","form_type":"4"}},{"id":1852397,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-17T01:17:22.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":34735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34735,"derivative":{"exercise_price":4.33,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":34735},"source":{"system":"sec-edgar","filing":"0001209191-23-038191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038191/doc4.xml","form_type":"4"}},{"id":1852396,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-17T01:17:22.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":23443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":29437,"source":{"system":"sec-edgar","filing":"0001209191-23-038191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038191/doc4.xml","form_type":"4"}},{"id":1860518,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-06-09T16:31:57.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter until the option became fully vested on June 12, 2022."}],"balance_after":96350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001619856-23-000073","document":"wk-form4_1686342698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000073/wk-form4_1686342698.xml","form_type":"4"}},{"id":1860517,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-09T16:31:57.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001619856-23-000073","document":"wk-form4_1686342698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000073/wk-form4_1686342698.xml","form_type":"4"}},{"id":1941706,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-03-22T16:16:22.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter until the option became fully vested on June 12, 2022."}],"balance_after":106350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001619856-23-000039","document":"wf-form4_167951616420908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000039/wf-form4_167951616420908.xml","form_type":"4"}},{"id":1941705,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-22T16:16:22.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001619856-23-000039","document":"wf-form4_167951616420908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000039/wf-form4_167951616420908.xml","form_type":"4"}},{"id":1995969,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:14:23.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":510500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":510500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":510500},"source":{"system":"sec-edgar","filing":"0001619856-23-000028","document":"wf-form4_167719043346430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000028/wf-form4_167719043346430.xml","form_type":"4"}},{"id":2228008,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:40:09.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":17865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":17865,"derivative":{"exercise_price":7.33,"expiration_date":"2031-06-15","underlying":"Class A Common Stock","underlying_shares":17865},"source":{"system":"sec-edgar","filing":"0001209191-22-038103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038103/doc4.xml","form_type":"4"}},{"id":2228007,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T22:40:09.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":5994,"source":{"system":"sec-edgar","filing":"0001209191-22-038103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038103/doc4.xml","form_type":"4"}},{"id":2276200,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2022-05-10T19:32:21.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to this option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":116350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-028170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122028170/doc4.xml","form_type":"4"}},{"id":2276199,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-10T19:32:21.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-22-028170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122028170/doc4.xml","form_type":"4"}},{"id":2276194,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2022-05-10T19:29:15.000Z","date":"2022-01-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to this option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":126350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-028169","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122028169/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-27"}},{"id":2276193,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-10T19:29:15.000Z","date":"2022-01-26","kind":"exercise","acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4/A is being filed to correct an inadvertent error in the original Form 4 filed January 27, 2022 attributing direct ownership of 3,349,395 shares listed in column 5 to the reporting person. As described in a Form 5 filed on February 9, 2022, on September 27, 2021, these 3,349,395 shares were transferred to a trust for which the reporting person and her spouse serve as a Co-Trustees."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-028169","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122028169/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-27"}},{"id":2406425,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-09T16:25:45.000Z","date":"2021-09-27","kind":"gift","acquired":true,"shares":3349395,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents transfer of shares to The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse."}],"balance_after":3349395,"source":{"system":"sec-edgar","filing":"0001209191-22-008027","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122008027/doc5.xml","form_type":"5"}},{"id":2406424,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-09T16:25:45.000Z","date":"2021-09-27","kind":"gift","acquired":false,"shares":3349395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents transfer of shares to The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-008027","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122008027/doc5.xml","form_type":"5"}},{"id":2424053,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2022-01-27T16:41:41.000Z","date":"2022-01-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on June 12, 2022, subject to the reporting person's continued services to the Issuer through the applicable vesting dates."}],"balance_after":126350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-005222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122005222/doc4.xml","form_type":"4"}},{"id":2424052,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-27T16:41:41.000Z","date":"2022-01-26","kind":"exercise","acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"balance_after":3359395,"source":{"system":"sec-edgar","filing":"0001209191-22-005222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919122005222/doc4.xml","form_type":"4"}},{"id":2462461,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T17:27:49.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":411000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":411000,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":411000},"source":{"system":"sec-edgar","filing":"0001209191-21-070804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000120919121070804/doc4.xml","form_type":"4"}},{"id":2515194,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-13T00:45:59.000Z","date":"2021-11-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on December 9, 2021."}],"balance_after":30000,"derivative":{"exercise_price":35.25,"expiration_date":"2031-11-09","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-064362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919121064362/doc4.xml","form_type":"4"}}]}